Human Milk Oligosaccharide (HMO) Market Outlook from 2024 to 2034
The global human milk oligosaccharide (HMO) market is estimated to reach US$ 100.8 million in 2024. Over the forecast period, human milk oligosaccharide sales are poised to increase at a CAGR of 6.5%. The global industry is estimated to reach a value of US$ 161.6 million by 2034.
Attributes
Key Insights
Estimated Global Human Milk Oligosaccharide (HMO) Market Size (2024E)
US$ 100.8 million
Projected Human Milk Oligosaccharide (HMO) Market Value (2034F)
US$ 161.6 million
Value-based CAGR (2024 to 2034)
6.5%
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Global Market Highlights
Rising consumer awareness of the value of gut health and increasing demand for dietary supplements are driving the human milk oligosaccharide market growth.
HMOs, known for their antimicrobial and prebiotic properties, are set to be commonly used in infant formulas, pharmaceuticals, and functional foods.
The HMO industry is expected to rise due to population growth, high mortality rates, and increased health awareness.
Rising prevalence of chronic ailments like gut diseases, diabetes, high blood pressure, and rickets drives demand for functional food and beverages, thereby boosting the human milk oligosaccharide market.
Infant formula and baby food industries are expected to experience significant growth due to rising demand, surging HMO production, and regulatory approval.
Ongoing research continues to uncover new health benefits associated with specific HMO structures. It is projected to expand the potential applications beyond infant nutrition, thereby fueling the market.
2019 to 2023 Human Milk Oligosaccharide (HMO) Market Growth Outlook
From 2019 to 2023, the global human milk oligosaccharide market witnessed steady growth in sales, driven by increasing awareness of their health benefits, particularly in infant nutrition.
Researchers have developed alternative methods for extracting HMOs from human breast milk, such as microbial fermentation and enzymatic synthesis. These are making it feasible to produce HMOs at scale.
Growing interest in HMOs has attracted investments from both established and start-up infant nutrition industry players. Rising partnerships between companies, research institutions, and universities are facilitating research and product development.
Increased awareness of breastfeeding and human milk components has boosted consumer interest in HMO-containing products. Education initiatives, marketing campaigns, and healthcare professional endorsements are promoting acceptance.
By 2034, human milk oligosaccharide sales are poised to increase at a CAGR of 6.5%.
Heightened demand is anticipated due to several factors, including continued research revealing new health benefits of HMOs.
Expanding applications beyond infant nutrition into areas like dietary supplements and rising preference for natural and bioactive ingredients are set to aid demand.
Regulatory support and production technology advancements are expected to fuel market growth during this period.
Manufacturers are likely to invest more in production capacity expansion, research & development, and marketing efforts. These strategies are expected to meet the growing demand and capitalize on the opportunities the expanding HMO market presents.
Find your sweet spots for generating winning opportunities in this market.
Semi-annual Market Update
Market Statistics
Details
Jul to Dec (H2), 2022 (A)
6.8%
Jan to Jun (H1), 2022 (A)
6.2%
Jan to Jun (H1), 2023 Projected (P)
7.3%
Jan to Jun (H1), 2023 Outlook (O)
6.9%
Jan to Jun (H1), 2024 Projected (P)
10.0%
Jul to Dec (H2), 2023 Outlook (O)
9.1%
Jul to Dec (H2), 2023 Projected (P)
8.8%
Key Human Milk Oligosaccharide (HMO) Market Trends
Increasing demand for HMOs in infant nutrition due to their role in mimicking the benefits of breast milk
Expansion of research into novel HMO structures and their potential health benefits
Rising interest in HMO supplementation for preterm infants to support gut health and immune function
Growing partnerships between HMO suppliers and infant formula manufacturers to enhance product offerings
Development of HMO-based functional foods for adults targeting gut health and immune support
Increasing investment in HMO production technologies to meet growing demand
Regulatory advancements to establish standards and guidelines for HMO supplementation in infant formula
Emergence of personalized nutrition solutions incorporating HMOs based on individual health needs and microbiome profiles
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Restraining Factors in Human Milk Oligosaccharide (HMO) Market
The complex and costly production of HMOs, especially through chemical or enzymatic methods, is set to hinder widespread adoption, particularly in cost-sensitive markets or regions with limited resources.
Regulatory approvals for novel food ingredients, including HMOs, are expected to be complex and time-consuming, potentially causing delays or uncertainties in product development and market entry.
HMOs, naturally found in breast milk, pose challenges in obtaining other sources due to scalability and yield optimization concerns, potentially limiting market growth and availability of HMO-fortified products.
HMOs face competition from other prebiotics, probiotics, and functional ingredients. This necessitates manufacturers to differentiate their products and showcase their unique value proposition to consumers and healthcare professionals.
Comparative View of Adjacent Markets
The global human milk oligosaccharide industry is likely to be impacted by the peer or tangential markets in the food and beverages division. These include the infant formula ingredient market and the infant nutritional premix industry. Demand for human milk oligosaccharides is expected to rise at a higher CAGR during the forecast period.
Human Milk Oligosaccharide Market:
Attributes
Human Milk Oligosaccharide Market
CAGR (2024 to 2034)
6.5%
Growth Factor
Consumer interest in HMOs is increasing due to growing awareness of early nutrition, leading manufacturers to invest in consumer education initiatives to differentiate their products.
Key Trends
Research on HMOs is enhancing the understanding of their impact on gut health, immune function, and neurological development, with a focus on identifying novel HMOs and optimizing production methods.
Infant Formula Ingredient Market:
Attributes
Infant Formula Ingredient Market
CAGR (2024 to 2034)
6.3%
Growth Factor
Rising demand for premium infant formula products with advanced nutritional ingredients is driving growth in the infant formula ingredient market.
Opportunity
Expansion of the global infant formula market in emerging economies and increasing adoption of specialty ingredients like HMOs present significant opportunities for ingredient suppliers.
Key Trends
Market expansion is being fueled by innovation in ingredient sourcing & formulation, focus on natural & organic ingredients, and partnerships between manufacturers & suppliers.
Infant Nutritional Premix Market:
Attributes
Infant Nutritional Premix Market
CAGR (2024 to 2034)
4.0%
Growth Factor
Rising global birth rates and a growing focus on early childhood nutrition are fueling demand for infant nutritional premixes.
Opportunity
Increasing consumer awareness of the importance of fortified infant foods and expansion of the infant formula market are creating opportunities for premix manufacturers.
Key Trends
Shift toward organic and clean label premix formulations and customization of premixes to meet specific nutritional requirements are driving the market.
Country-wise Insights
The table below shows the estimated growth rates of the leading countries. The United Kingdom, China, and Germany are set to record high CAGRs of 6.2%, 5.5%, and 5.9%, respectively, through 2034.
Countries
CAGR
United States
4.5%
United Kingdom
6.2%
Germany
5.9%
China
5.5%
Japan
4.8%
Research and Development Activities in the United States Upscaling the Market
The United States is expected to exhibit a CAGR of 4.5% through 2034. Key factors supporting the market growth are:
The United States has a developed infrastructure for research and development, resulting in innovation in infant nutrition, which is driving market growth.
The United States infant formula market is gaining popularity due to growing recognition of breastfeeding benefits and early nutrition. It is mainly pushed by parents seeking products resembling human breast milk.
Several companies and academic institutions in the United States work on HMO-related research & development projects. These projects concentrate on enhancing production techniques, investigating novel uses, and comprehending the health advantages of HMOs in newborn nutrition.
Increasing Government Initiatives to Surge Sales in China
During the forecast period, China is expected to expand at a CAGR of 5.5%. Top factors supporting the market expansion in the country include:
Increasing disposable income and urbanization in China are expected to boost demand for premium infant nutrition products fortified with HMOs.
Growing government's initiative to promote breastfeeding and regulate infant formula standards is encouraging the incorporation of HMO in infant formula.
China often fosters collaborations between academic institutions, research facilities, and industry players. These are further developing information sharing, expediting research, and enhancing creativity in HMO creation and usage.
High Prevalence of Digestive Disorders and Food Sensitivities Propelling Japan
Demand for human milk oligosaccharides in Japan is anticipated to rise at a steady CAGR of 4.8% during the forecast period. This is attributable to a combination of factors, including:
Rising prevalence of digestive disorders and food sensitivities among infants is set to result in growing sales of HMOs in Japan.
In Japan, consumer knowledge of HMOs is increasing, with marketing campaigns, educational initiatives, and healthcare industry endorsements boosting parental and caregiver acceptance.
Category-wise Insights
The section below shows the fucosylated segment dominating by product type. The segment is predicted to reach US$ 42.9 million in 2034. Based on end-use, the infant formula segment is anticipated to generate a dominant share through 2024. It is set to reach US$ 99.2 million by 2024.
Segment
Infant Formula (End-use)
Market Value (2024)
US$ 99.2 million
Demand for Human Milk Oligosaccharides to Remain High in Infant Formula
Infant formula mimics breast milk's composition to provide effective nutrients to non-breastfed infants.
HMOs, found in breast milk, are crucial for gut health, immune function, and development, making their inclusion in infant formulations essential for similar benefits.
HMOs are increasingly used in infant formulations due to their specific nutritional requirements and strict regulatory standards, making them a popular choice for infant health supplements.
Fucosylated HMOs Segment Tops the Product Type Category
Segment
Fucosylated (Product Type)
Market Value (2034)
US$ 42.9 million
Fucosylated HMOs, like 2'-fucosyllactose and 3-fucosyllactose, are gaining traction as they are crucial for infant gut health. These also help in promoting beneficial bacteria growth and inhibiting pathogen adhesion.
Manufacturers prioritize fucosylated HMOs to mimic breast milk's health benefits and support infant development. They are projected to contribute to a healthy gut microbiome essential for immune function and nutrient absorption.
Competitive Landscape
The human milk oligosaccharide (HMO) market has a diverse and dynamic competitive landscape. Leading companies are focusing on research & development, new formulations, and sustainable sourcing to expand their market reach.
Key players emphasize product certifications, environmentally friendly practices, and satisfying the increased demand for natural and sustainable ingredients.
For instance
In 2021, BASF announced the approval of PREBILAC, its 2’-FL brand, by Australia's Therapeutic Goods Administration (TGA). This approval establishes PREBILAC as the initial and exclusive 2’-FL ingredient to receive recognition from TGA as a prebiotic ingredient.
In 2022, Kyowa Hakko Bio Co. Ltd, a subsidiary of Kirin Holdings Company Limited, finalized the construction of a manufacturing facility. It is dedicated to the production of human milk oligosaccharides (HMOs) at its Thai subsidiary, Thai Kyowa Biotechnologies Co, Ltd.
Key Companies Profiled
Jennewein Biotechnologie GmbH
KYOWA HAKKO BIO CO. LTD.
DSM
Nestle Health Science
DUPONT
zuChem Inc.
Glycosyn LLC
Elicityl SA
Dextra Laboratories Limited
Carbosynth Limited
Key Coverage in the Global Human Milk Oligosaccharide Industry Research Report
Adjacent Study on Human Milk Oligosaccharides Benefits and Nutritional Products Human Milk Oligosaccharides
Detailed Market Analysis of Human Milk Oligosaccharides Supplement
Ongoing Innovations in Human Milk Oligosaccharides Formula
Growth Prospects for Baby Food Market in the United States
Top Players in Baby Food and Infant Formula Market
Human Milk Oligosaccharides and Immune System Development
Human Milk Oligosaccharide (HMO) Market Segmentation by Category
By Product Type:
Fucosylated
2FL
2FL DFL
3FL
Silylated
3SL
6SL
Non-fucosylated Neutral
LNT
LNnT
LNFP
By End-use:
Infant Formula
Dietary Supplements
By Region:
North America
Latin America
Europe
South Asia
East Asia
Middle East and Africa
Oceania
Frequently Asked Questions
How big is the human milk oligosaccharide market?
The market is set to reach US$ 100.8 million in 2024.
What is the forecast for the human milk oligosaccharide market?
Demand for human milk oligosaccharide is slated to expand at a 6.5% CAGR by 2034.
What is the outlook for the human milk oligosaccharide market?
The market is set to reach US$ 161.6 million in 2034.
Who are the key players in the human milk oligosaccharide market?
KYOWA HAKKO BIO CO. LTD., DSM, and Nestle Health Science are the key players.
Which product type would lead the human milk oligosaccharide market?
Fucosylated segment is estimated to hold a significant market share in 2024.
Which region is expected to hold the leading market share by 2034?
Asia Pacific is expected to hold a market share of 39.2% by 2034.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition
3. Market Dynamics
3.1. Drivers
3.1.1. Supply Side Drivers
3.1.2. Demand Side drivers
3.1.3. Economic Side Drivers
3.2. Restraints
3.3. Opportunity
3.4. Market trends By Region
3.5. Forecast Factors - Relevance & Impact
3.6. Key Regulations and Policies
4. Value Chain Analysis
4.1. Operating Margins at Each Node of the Supply Chain
4.2. List of Active Market Participants
5. Global - Pricing Analysis
5.1. Price Point Assessment by Region
5.1.1. Manufacturer-Level Pricing
5.1.2. Distributor Level Pricing
5.2. Price Point Assessment By Product
5.3. Price Forecast till 2034
6. Global Market Size (in Value (US$ million) and Volume (MT) Analysis 2019 to 2023 and Forecast, 2024 to 2034
6.1. Historical Market Size (in Value (US$ million) and Volume (MT) Analysis, 2019 to 2023
6.2. Current and Future Market Size (in Value (US$ million) and Volume (MT) Analysis, 2024 to 2034
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (in Value (US$ million) and Volume (MT) Analysis By Product Type, 2019 to 2023
7.3. Current and Future Market Size (in Value (US$ million) and Volume (MT) Analysis and Forecast By Product Type, 2024 to 2034
7.3.1. Fucosylated
7.3.1.1. 2FL
7.3.1.2. 2FL DFL
7.3.1.3. 3FL
7.3.2. Silylated
7.3.2.1. 3SL
7.3.2.2. 6SL
7.3.3. Non-fucosylated Neutral
7.3.3.1. LNT
7.3.3.2. LNnT
7.3.3.3. LNFP
7.4. Market Attractiveness Analysis By Product Type
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-use
8.1. Introduction / Key Findings
8.2. Historical Market Size (in Value (US$ million) and Volume (MT) Analysis By End-use, 2019 to 2023
8.3. Current and Future Market Size (in Value (US$ million) and Volume (MT) Analysis and Forecast By End-use, 2024 to 2034
8.3.1. Infant Formula
8.3.2. Dietary Supplements
8.4. Market Attractiveness Analysis By End-use
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region
9.1. Introduction
9.2. Historical Market Size (in Value (US$ million) and Volume (MT) Analysis By Region, 2019 to 2023
9.3. Current Market Size (in Value (US$ million) and Volume (MT) Analysis and Forecast By Region, 2024 to 2034
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. East Asia
9.3.5. South Asia
9.3.6. Oceania
9.3.7. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
10.1. Introduction
10.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2019 to 2023
10.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2024 to 2034
10.3.1. By Country
10.3.1.1. United States
10.3.1.2. Canada
10.3.2. By Product Type
10.3.3. By End-use
10.4. Market Attractiveness Analysis
10.4.1. By Country
10.4.2. By Product Type
10.4.3. By End-use
10.5. Key Takeaways
11. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
11.1. Introduction
11.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2019 to 2023
11.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2024 to 2034
11.3.1. By Country
11.3.1.1. Brazil
11.3.1.2. Mexico
11.3.1.3. Argentina
11.3.1.4. Rest of Latin America
11.3.2. By Product Type
11.3.3. By End-use
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Product Type
11.4.3. By End-use
11.5. Key Takeaways
12. Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034
12.1. Introduction
12.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2019 to 2023
12.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2024 to 2034
12.3.1. By Country
12.3.1.1. Germany
12.3.1.2. United Kingdom
12.3.1.3. France
12.3.1.4. Italy
12.3.1.5. Spain
12.3.1.6. BENELUX
12.3.1.7. Nordic
12.3.1.8. Russia
12.3.1.9. Poland
12.3.1.10. Rest of Europe
12.3.2. By Product Type
12.3.3. By End-use
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product Type
12.4.3. By End-use
12.5. Key Takeaways
13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034
13.1. Introduction
13.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2019 to 2023
13.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2024 to 2034
13.3.1. By Country
13.3.1.1. China
13.3.1.2. Japan
13.3.1.3. South Korea
13.3.2. By Product Type
13.3.3. By End-use
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product Type
13.4.3. By End-use
13.5. Key Takeaways
14. South Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034
14.1. Introduction
14.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2019 to 2023
14.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2024 to 2034
14.3.1. By Country
14.3.1.1. India
14.3.1.2. Thailand
14.3.1.3. Malaysia
14.3.1.4. Indonesia
14.3.1.5. Singapore
14.3.1.6. Vietnam
14.3.1.7. Philippines
14.3.1.8. Rest of South Asia
14.3.2. By Product Type
14.3.3. By End-use
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product Type
14.4.3. By End-use
14.5. Key Takeaways
15. Oceania Market Analysis 2019 to 2023 and Forecast 2024 to 2034
15.1. Introduction
15.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2019 to 2023
15.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2024 to 2034
15.3.1. By Country
15.3.1.1. Australia
15.3.1.2. New Zealand
15.3.2. By Product Type
15.3.3. By End-use
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product Type
15.4.3. By End-use
15.5. Key Takeaways
16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034
16.1. Introduction
16.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2019 to 2023
16.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2024 to 2034
16.3.1. By Country
16.3.1.1. GCC Countries
16.3.1.2. Turkiye
16.3.1.3. Egypt
16.3.1.4. South Africa
16.3.1.5. Rest of Middle East and Africa
16.3.2. By Product Type
16.3.3. By End-use
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product Type
16.4.3. By End-use
16.5. Key Takeaways
17. Country-level Market Analysis, 2022
17.1. United States Market Analysis
17.1.1. By Product Type
17.1.2. By End-use
17.2. Canada Market Analysis
17.2.1. By Product Type
17.2.2. By End-use
17.3. Brazil Market Analysis
17.3.1. By Product Type
17.3.2. By End-use
17.4. Mexico Market Analysis
17.4.1. By Product Type
17.4.2. By End-use
17.5. Argentina Market Analysis
17.5.1. By Product Type
17.5.2. By End-use
17.6. Germany Market Analysis
17.6.1. By Product Type
17.6.2. By End-use
17.7. United Kingdom Market Analysis
17.7.1. By Product Type
17.7.2. By End-use
17.8. France Market Analysis
17.8.1. By Product Type
17.8.2. By End-use
17.9. Italy Market Analysis
17.9.1. By Product Type
17.9.2. By End-use
17.10. Spain Market Analysis
17.10.1. By Product Type
17.10.2. By End-use
17.11. Belgium Market Analysis
17.11.1. By Product Type
17.11.2. By End-use
17.12. Netherlands Market Analysis
17.12.1. By Product Type
17.12.2. By End-use
17.13. Nordic Market Analysis
17.13.1. By Product Type
17.13.2. By End-use
17.14. Russia Market Analysis
17.14.1. By Product Type
17.14.2. By End-use
17.15. Poland Market Analysis
17.15.1. By Product Type
17.15.2. By End-use
17.16. China Market Analysis
17.16.1. By Product Type
17.16.2. By End-use
17.17. Japan Market Analysis
17.17.1. By Product Type
17.17.2. By End-use
17.18. South Korea Market Analysis
17.18.1. By Product Type
17.18.2. By End-use
17.19. India Market Analysis
17.19.1. By Product Type
17.19.2. By End-use
17.20. Thailand Market Analysis
17.20.1. By Product Type
17.20.2. By End-use
17.21. Malaysia Market Analysis
17.21.1. By Product Type
17.21.2. By End-use
17.22. Vietnam Market Analysis
17.22.1. By Product Type
17.22.2. By End-use
17.23. Philippines Market Analysis
17.23.1. By Product Type
17.23.2. By End-use
17.24. Indonesia Market Analysis
17.24.1. By Product Type
17.24.2. By End-use
17.25. Singapore Market Analysis
17.25.1. By Product Type
17.25.2. By End-use
17.26. Australia Market Analysis
17.26.1. By Product Type
17.26.2. By End-use
17.27. New Zealand Market Analysis
17.27.1. By Product Type
17.27.2. By End-use
17.28. GCC Countries Market Analysis
17.28.1. By Product Type
17.28.2. By End-use
17.29. Turkiye Market Analysis
17.29.1. By Product Type
17.29.2. By End-use
17.30. Egypt Market Analysis
17.30.1. By Product Type
17.30.2. By End-use
17.31. South Africa Market Analysis
17.31.1. By Product Type
17.31.2. By End-use
18. Market Structure Analysis
18.1. Global Competition - a Dashboard View
18.2. Industry Structure Analysis
18.2.1. % tier 1 market players
18.2.2. % tier 2 market players
18.2.3. % tier 3 market players
18.3. Global Market Company Share Analysis
18.3.1. For Tier 1 Market Players, 2024
18.3.2. Company Market Share Analysis of Top 5 Players, By Region
18.4. Key Participants Market Presence (Intensity Mapping) by Region
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. Jennewein Biotechnologie GmbH
19.3.1.1. Product Portfolio
19.3.1.2. Product Claim
19.3.1.3. Revenue by Market Segments (Product/ channel/Region)
19.3.1.4. Sales Footprint
19.3.1.5. Strategy Overview
19.3.1.5.1. Marketing Strategy
19.3.1.5.2. Product Strategy
19.3.1.5.3. Channel Strategy
19.3.1.6. SWOT Analysis
19.3.2. KYOWA HAKKO BIO CO. LTD.
19.3.3. DSM
19.3.4. Nestle Health Science
19.3.5. DUPONT
19.3.6. zuChem Inc.
19.3.7. Glycosyn LLC
19.3.8. Elicityl SA
19.3.9. Dextra Laboratories Limited
19.3.10. Carbosynth Limited
19.3.11. Other Players (On Additional Requests)
20. Assumptions and Acronyms Used21. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ million) Forecast by Region, 2019 to 2034
Table 2: Global Market Volume (MT) Forecast by Region, 2019 to 2034
Table 3: Global Market Value (US$ million) Forecast by Product Type, 2019 to 2034
Table 4: Global Market Volume (MT) Forecast by Product Type, 2019 to 2034
Table 5: Global Market Value (US$ million) Forecast by End-use, 2019 to 2034
Table 6: Global Market Volume (MT) Forecast by End-use, 2019 to 2034
Table 7: North America Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 8: North America Market Volume (MT) Forecast by Country, 2019 to 2034
Table 9: North America Market Value (US$ million) Forecast by Product Type, 2019 to 2034
Table 10: North America Market Volume (MT) Forecast by Product Type, 2019 to 2034
Table 11: North America Market Value (US$ million) Forecast by End-use, 2019 to 2034
Table 12: North America Market Volume (MT) Forecast by End-use, 2019 to 2034
Table 13: Latin America Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 14: Latin America Market Volume (MT) Forecast by Country, 2019 to 2034
Table 15: Latin America Market Value (US$ million) Forecast by Product Type, 2019 to 2034
Table 16: Latin America Market Volume (MT) Forecast by Product Type, 2019 to 2034
Table 17: Latin America Market Value (US$ million) Forecast by End-use, 2019 to 2034
Table 18: Latin America Market Volume (MT) Forecast by End-use, 2019 to 2034
Table 19: Europe Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 20: Europe Market Volume (MT) Forecast by Country, 2019 to 2034
Table 21: Europe Market Value (US$ million) Forecast by Product Type, 2019 to 2034
Table 22: Europe Market Volume (MT) Forecast by Product Type, 2019 to 2034
Table 23: Europe Market Value (US$ million) Forecast by End-use, 2019 to 2034
Table 24: Europe Market Volume (MT) Forecast by End-use, 2019 to 2034
Table 25: East Asia Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 26: East Asia Market Volume (MT) Forecast by Country, 2019 to 2034
Table 27: East Asia Market Value (US$ million) Forecast by Product Type, 2019 to 2034
Table 28: East Asia Market Volume (MT) Forecast by Product Type, 2019 to 2034
Table 29: East Asia Market Value (US$ million) Forecast by End-use, 2019 to 2034
Table 30: East Asia Market Volume (MT) Forecast by End-use, 2019 to 2034
Table 31: South Asia Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 32: South Asia Market Volume (MT) Forecast by Country, 2019 to 2034
Table 33: South Asia Market Value (US$ million) Forecast by Product Type, 2019 to 2034
Table 34: South Asia Market Volume (MT) Forecast by Product Type, 2019 to 2034
Table 35: South Asia Market Value (US$ million) Forecast by End-use, 2019 to 2034
Table 36: South Asia Market Volume (MT) Forecast by End-use, 2019 to 2034
Table 37: Oceania Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 38: Oceania Market Volume (MT) Forecast by Country, 2019 to 2034
Table 39: Oceania Market Value (US$ million) Forecast by Product Type, 2019 to 2034
Table 40: Oceania Market Volume (MT) Forecast by Product Type, 2019 to 2034
Table 41: Oceania Market Value (US$ million) Forecast by End-use, 2019 to 2034
Table 42: Oceania Market Volume (MT) Forecast by End-use, 2019 to 2034
Table 43: Middle East and Africa Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 44: Middle East and Africa Market Volume (MT) Forecast by Country, 2019 to 2034
Table 45: Middle East and Africa Market Value (US$ million) Forecast by Product Type, 2019 to 2034
Table 46: Middle East and Africa Market Volume (MT) Forecast by Product Type, 2019 to 2034
Table 47: Middle East and Africa Market Value (US$ million) Forecast by End-use, 2019 to 2034
Table 48: Middle East and Africa Market Volume (MT) Forecast by End-use, 2019 to 2034
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ million) by Product Type, 2024 to 2034
Figure 2: Global Market Value (US$ million) by End-use, 2024 to 2034
Figure 3: Global Market Value (US$ million) by Region, 2024 to 2034
Figure 4: Global Market Value (US$ million) Analysis by Region, 2019 to 2034
Figure 5: Global Market Volume (MT) Analysis by Region, 2019 to 2034
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 8: Global Market Value (US$ million) Analysis by Product Type, 2019 to 2034
Figure 9: Global Market Volume (MT) Analysis by Product Type, 2019 to 2034
Figure 10: Global Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 11: Global Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 12: Global Market Value (US$ million) Analysis by End-use, 2019 to 2034
Figure 13: Global Market Volume (MT) Analysis by End-use, 2019 to 2034
Figure 14: Global Market Value Share (%) and BPS Analysis by End-use, 2024 to 2034
Figure 15: Global Market Y-o-Y Growth (%) Projections by End-use, 2024 to 2034
Figure 16: Global Market Attractiveness by Product Type, 2024 to 2034
Figure 17: Global Market Attractiveness by End-use, 2024 to 2034
Figure 18: Global Market Attractiveness by Region, 2024 to 2034
Figure 19: North America Market Value (US$ million) by Product Type, 2024 to 2034
Figure 20: North America Market Value (US$ million) by End-use, 2024 to 2034
Figure 21: North America Market Value (US$ million) by Country, 2024 to 2034
Figure 22: North America Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 23: North America Market Volume (MT) Analysis by Country, 2019 to 2034
Figure 24: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 25: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 26: North America Market Value (US$ million) Analysis by Product Type, 2019 to 2034
Figure 27: North America Market Volume (MT) Analysis by Product Type, 2019 to 2034
Figure 28: North America Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 29: North America Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 30: North America Market Value (US$ million) Analysis by End-use, 2019 to 2034
Figure 31: North America Market Volume (MT) Analysis by End-use, 2019 to 2034
Figure 32: North America Market Value Share (%) and BPS Analysis by End-use, 2024 to 2034
Figure 33: North America Market Y-o-Y Growth (%) Projections by End-use, 2024 to 2034
Figure 34: North America Market Attractiveness by Product Type, 2024 to 2034
Figure 35: North America Market Attractiveness by End-use, 2024 to 2034
Figure 36: North America Market Attractiveness by Country, 2024 to 2034
Figure 37: Latin America Market Value (US$ million) by Product Type, 2024 to 2034
Figure 38: Latin America Market Value (US$ million) by End-use, 2024 to 2034
Figure 39: Latin America Market Value (US$ million) by Country, 2024 to 2034
Figure 40: Latin America Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 41: Latin America Market Volume (MT) Analysis by Country, 2019 to 2034
Figure 42: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 43: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 44: Latin America Market Value (US$ million) Analysis by Product Type, 2019 to 2034
Figure 45: Latin America Market Volume (MT) Analysis by Product Type, 2019 to 2034
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 48: Latin America Market Value (US$ million) Analysis by End-use, 2019 to 2034
Figure 49: Latin America Market Volume (MT) Analysis by End-use, 2019 to 2034
Figure 50: Latin America Market Value Share (%) and BPS Analysis by End-use, 2024 to 2034
Figure 51: Latin America Market Y-o-Y Growth (%) Projections by End-use, 2024 to 2034
Figure 52: Latin America Market Attractiveness by Product Type, 2024 to 2034
Figure 53: Latin America Market Attractiveness by End-use, 2024 to 2034
Figure 54: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 55: Europe Market Value (US$ million) by Product Type, 2024 to 2034
Figure 56: Europe Market Value (US$ million) by End-use, 2024 to 2034
Figure 57: Europe Market Value (US$ million) by Country, 2024 to 2034
Figure 58: Europe Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 59: Europe Market Volume (MT) Analysis by Country, 2019 to 2034
Figure 60: Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 61: Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 62: Europe Market Value (US$ million) Analysis by Product Type, 2019 to 2034
Figure 63: Europe Market Volume (MT) Analysis by Product Type, 2019 to 2034
Figure 64: Europe Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 65: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 66: Europe Market Value (US$ million) Analysis by End-use, 2019 to 2034
Figure 67: Europe Market Volume (MT) Analysis by End-use, 2019 to 2034
Figure 68: Europe Market Value Share (%) and BPS Analysis by End-use, 2024 to 2034
Figure 69: Europe Market Y-o-Y Growth (%) Projections by End-use, 2024 to 2034
Figure 70: Europe Market Attractiveness by Product Type, 2024 to 2034
Figure 71: Europe Market Attractiveness by End-use, 2024 to 2034
Figure 72: Europe Market Attractiveness by Country, 2024 to 2034
Figure 73: East Asia Market Value (US$ million) by Product Type, 2024 to 2034
Figure 74: East Asia Market Value (US$ million) by End-use, 2024 to 2034
Figure 75: East Asia Market Value (US$ million) by Country, 2024 to 2034
Figure 76: East Asia Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 77: East Asia Market Volume (MT) Analysis by Country, 2019 to 2034
Figure 78: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 79: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 80: East Asia Market Value (US$ million) Analysis by Product Type, 2019 to 2034
Figure 81: East Asia Market Volume (MT) Analysis by Product Type, 2019 to 2034
Figure 82: East Asia Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 83: East Asia Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 84: East Asia Market Value (US$ million) Analysis by End-use, 2019 to 2034
Figure 85: East Asia Market Volume (MT) Analysis by End-use, 2019 to 2034
Figure 86: East Asia Market Value Share (%) and BPS Analysis by End-use, 2024 to 2034
Figure 87: East Asia Market Y-o-Y Growth (%) Projections by End-use, 2024 to 2034
Figure 88: East Asia Market Attractiveness by Product Type, 2024 to 2034
Figure 89: East Asia Market Attractiveness by End-use, 2024 to 2034
Figure 90: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 91: South Asia Market Value (US$ million) by Product Type, 2024 to 2034
Figure 92: South Asia Market Value (US$ million) by End-use, 2024 to 2034
Figure 93: South Asia Market Value (US$ million) by Country, 2024 to 2034
Figure 94: South Asia Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 95: South Asia Market Volume (MT) Analysis by Country, 2019 to 2034
Figure 96: South Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 97: South Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 98: South Asia Market Value (US$ million) Analysis by Product Type, 2019 to 2034
Figure 99: South Asia Market Volume (MT) Analysis by Product Type, 2019 to 2034
Figure 100: South Asia Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 101: South Asia Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 102: South Asia Market Value (US$ million) Analysis by End-use, 2019 to 2034
Figure 103: South Asia Market Volume (MT) Analysis by End-use, 2019 to 2034
Figure 104: South Asia Market Value Share (%) and BPS Analysis by End-use, 2024 to 2034
Figure 105: South Asia Market Y-o-Y Growth (%) Projections by End-use, 2024 to 2034
Figure 106: South Asia Market Attractiveness by Product Type, 2024 to 2034
Figure 107: South Asia Market Attractiveness by End-use, 2024 to 2034
Figure 108: South Asia Market Attractiveness by Country, 2024 to 2034
Figure 109: Oceania Market Value (US$ million) by Product Type, 2024 to 2034
Figure 110: Oceania Market Value (US$ million) by End-use, 2024 to 2034
Figure 111: Oceania Market Value (US$ million) by Country, 2024 to 2034
Figure 112: Oceania Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 113: Oceania Market Volume (MT) Analysis by Country, 2019 to 2034
Figure 114: Oceania Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 115: Oceania Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 116: Oceania Market Value (US$ million) Analysis by Product Type, 2019 to 2034
Figure 117: Oceania Market Volume (MT) Analysis by Product Type, 2019 to 2034
Figure 118: Oceania Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 119: Oceania Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 120: Oceania Market Value (US$ million) Analysis by End-use, 2019 to 2034
Figure 121: Oceania Market Volume (MT) Analysis by End-use, 2019 to 2034
Figure 122: Oceania Market Value Share (%) and BPS Analysis by End-use, 2024 to 2034
Figure 123: Oceania Market Y-o-Y Growth (%) Projections by End-use, 2024 to 2034
Figure 124: Oceania Market Attractiveness by Product Type, 2024 to 2034
Figure 125: Oceania Market Attractiveness by End-use, 2024 to 2034
Figure 126: Oceania Market Attractiveness by Country, 2024 to 2034
Figure 127: Middle East and Africa Market Value (US$ million) by Product Type, 2024 to 2034
Figure 128: Middle East and Africa Market Value (US$ million) by End-use, 2024 to 2034
Figure 129: Middle East and Africa Market Value (US$ million) by Country, 2024 to 2034
Figure 130: Middle East and Africa Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 131: Middle East and Africa Market Volume (MT) Analysis by Country, 2019 to 2034
Figure 132: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 133: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 134: Middle East and Africa Market Value (US$ million) Analysis by Product Type, 2019 to 2034
Figure 135: Middle East and Africa Market Volume (MT) Analysis by Product Type, 2019 to 2034
Figure 136: Middle East and Africa Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 137: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 138: Middle East and Africa Market Value (US$ million) Analysis by End-use, 2019 to 2034
Figure 139: Middle East and Africa Market Volume (MT) Analysis by End-use, 2019 to 2034
Figure 140: Middle East and Africa Market Value Share (%) and BPS Analysis by End-use, 2024 to 2034
Figure 141: Middle East and Africa Market Y-o-Y Growth (%) Projections by End-use, 2024 to 2034
Figure 142: Middle East and Africa Market Attractiveness by Product Type, 2024 to 2034
Figure 143: Middle East and Africa Market Attractiveness by End-use, 2024 to 2034
Figure 144: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
